Loading clinical trials...
Loading clinical trials...
The goal of this sub-study of the RESTORE trial is to identify biomarkers associated with tumor hypoxia, identify biomarkers that differentiate pseudoprogression from true progression, and correlate b...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
NuvOx LLC
Collaborators
NCT07100730 · Neoplastic Disease, Glioblastoma, and more
NCT07420543 · Brain Tumors and/or Solid Tumors Including, Glioblastoma, and more
NCT05911230 · Glioblastoma (GBM)
NCT07472387 · Glioblastoma (GBM)
NCT05431348 · Glioblastoma (GBM)
Center for Neurosciences
Tucson, Arizona
Yale Cancer Center
New Haven, Connecticut
Saint Luke's Cancer Institute
Kansas City, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions